PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 9782898

Hormone replacement therapy.

M E Rousseau
View original source ↗Export metadata ↓

Abstract

For the large number of women who become menopausal each year, the decision of whether to use hormone replacement therapy is central. The author outlines treatment options, risks, and benefits of hormone therapy and examines likelihoods of outcomes. Based on the latest research, types of hormones available, prescription regimens, side effects, and alternatives to hormone therapy are discussed.

Explore related subjects

Estrogen Replacement TherapyFemaleHumansMenopauseMiddle AgedPatient CompliancePatient Education as TopicPatient SelectionJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M E Rousseau. 1998. Hormone replacement therapy.. https://pubmed.ncbi.nlm.nih.gov/9782898/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2000

Female sexual dysfunction: evaluation and treatment.

Sexual dysfunction includes desire, arousal, orgasmic and sex pain disorders (dyspareunia and vaginismus). Primary care physicians must assume a proactive role in the diagnosis and treatment of these disorders. Long-term medical diseases, minor ailments, medications and psychosocial difficulties, including prior physical or sexual abuse, are etiologic factors. Gynecologic maladies and cancers (including breast cancer) are also frequent sources of sexual dysfunction. Patient education and reassurance, with early diagnosis and intervention, are essential for effective treatment. Patient history and physical examination techniques, normal sexual responses and the factors that influence these responses, and the application of medical and gynecologic treatments to sexual issues are discussed. Basic treatment strategies, which may be successfully provided by primary care physicians for most sexual dysfunctions, are outlined. Referral can be reserved for patients who do not respond to therapy.

Estrogen Replacement Therapy↗
PubMed2000

Effects of hormone replacement therapy on lipid peroxides and oxidation system in postmenopausal women.

A short-term evaluation of 6 months of estrogen therapy on oxidant status in 38 postmenopausal women was conducted. The levels of serum lipid peroxidation products, glutathione (GSH) status, and glutathione-related enzymes were evaluated before and after 6 months of hormone replacement therapy. After 6 months of estrogen treatment there was a significantly increased concentration of thiobarbituric acid-reactive substances (TBARS), which are an end product of lipid peroxidation. This was accompanied by a significant increase in the activity of glutathione peroxidase (GSH-Px). However, the activities of glutathione reductase (GSSG-R) and superoxide dismutase (SOD) were significantly decreased and total protein thiols were reduced. Data suggest that hormone replacement therapy in postmenopausal women is associated with oxidant mechanisms.

Estrogen Replacement Therapy↗